Media Centre VideosSeptember 24, 2025Molecular Testing for Intestinal Protozoa: How a Laboratory Developed Test Compares to One That Is FDA-ClearedVideosSeptember 24, 2025Implementation of pan-enteric PCR screening at a UK general district hospital – benefits, pitfalls and lessons learntPublications, Articles & PresentationsFebruary 5, 2025Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling studyPublications, Articles & PresentationsAugust 30, 2025Surveillance of Viral Respiratory Infections within Maximum-Security Prison, AustraliaBlogJune 2, 2025Genetic Signatures Confirms Reliable Detection of Emerging COVID-19 Variant, NB.1.8.1EventsMarch 14, 2024BDL 2024NewsSeptember 24, 2024A warm welcome to Allison RossiterNewsNovember 22, 2024Genetic Signatures 2024 AGM HighlightsNewsJune 4, 2024FDA Clears Genetic Signatures’ Molecular Diagnostic Solution for Gastrointestinal ParasitesNewsJune 4, 2024Genetic Signatures Appoints Former Roche Diagnostics Executive Allison Rossiter as CEONewsApril 30, 2024Genetic Signatures farewells long-standing CEO & Director, Dr. John MelkiBlogAugust 29, 2023Genetic Signatures Announces Strategic Channel Partnership with Almog Diagnostic for Market Entry into Israel
VideosSeptember 24, 2025Molecular Testing for Intestinal Protozoa: How a Laboratory Developed Test Compares to One That Is FDA-Cleared
VideosSeptember 24, 2025Implementation of pan-enteric PCR screening at a UK general district hospital – benefits, pitfalls and lessons learnt
Publications, Articles & PresentationsFebruary 5, 2025Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study
Publications, Articles & PresentationsAugust 30, 2025Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia
BlogJune 2, 2025Genetic Signatures Confirms Reliable Detection of Emerging COVID-19 Variant, NB.1.8.1
NewsJune 4, 2024FDA Clears Genetic Signatures’ Molecular Diagnostic Solution for Gastrointestinal Parasites
NewsJune 4, 2024Genetic Signatures Appoints Former Roche Diagnostics Executive Allison Rossiter as CEO
BlogAugust 29, 2023Genetic Signatures Announces Strategic Channel Partnership with Almog Diagnostic for Market Entry into Israel
